Do all patients in the Intensive Care Unit (ICU) require Stress Ulcer Prophylaxis (SUP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stress Ulcer Prophylaxis in ICU Patients: Risk-Stratified Approach Required

Not all ICU patients require stress ulcer prophylaxis (SUP)—only those with specific risk factors for clinically important gastrointestinal bleeding should receive it. 1

Risk Factors That Mandate SUP

The 2024 Society of Critical Care Medicine guidelines clearly identify three primary risk factors that warrant SUP:

  • Coagulopathy (absolute risk increase of 4.8% for stress-related UGIB) 1, 2
  • Shock (absolute risk increase of 2.6% for stress-related UGIB) 1, 2
  • Chronic liver disease (absolute risk increase of 7.6% for stress-related UGIB) 1, 2

Mechanical ventilation alone does NOT necessitate SUP, contrary to older practice patterns. 1, 2 This represents a significant departure from historical recommendations where prolonged mechanical ventilation (>48 hours) was considered sufficient indication. 3

When NOT to Use SUP

Low-risk ICU patients who are enterally fed and lack the above risk factors should NOT receive SUP. 1 This is a conditional recommendation with very low certainty of evidence, but it addresses the widespread problem of SUP overuse—studies show 68.1% of ICU patients without risk factors inappropriately receive prophylaxis. 4

Role of Enteral Nutrition

Enteral nutrition itself provides protective effects, reducing absolute risk of stress-related UGIB by 0.3%. 2 However, even patients receiving enteral nutrition should receive SUP if they possess one or more of the three major risk factors listed above. 1, 2 This nuance is critical—enteral feeding is not sufficient protection in high-risk patients.

Medication Selection When SUP Is Indicated

When SUP is warranted based on risk factors:

  • Use either PPIs or H2RAs as first-line agents (both are acceptable; PPIs show relative risk reduction of 0.52 for clinically important UGIB) 1, 2
  • Administer low-dose therapy only: ≤40mg daily of esomeprazole, omeprazole, or pantoprazole 2
  • Either enteral or IV routes are acceptable 1, 2

Critical Discontinuation Criteria

SUP must be discontinued when risk factors resolve or before ICU transfer to prevent inappropriate continuation. 1, 2 This is essential because 60.4% of patients continue SUP after ICU transfer despite resolution of risk factors, and 31% are discharged home on agents without valid indication. 4

Important Caveats

Concurrent SUP with enteral nutrition may increase pneumonia risk, though the benefits in high-risk patients outweigh this concern. 1, 2 The older literature suggesting SUP increases ventilator-associated pneumonia has not definitively established impact on mortality and morbidity. 1

SUP has not demonstrated mortality benefit in critically ill patients—its purpose is solely to prevent clinically important bleeding (defined as bleeding causing hemodynamic instability or requiring transfusion). 1, 3

Special Population: Neurocritical Care

Neurocritical care patients warrant SUP due to physiologic changes causing gastric acid hypersecretion, even though this recommendation carries very low certainty of evidence. 1, 2

Algorithm for Decision-Making

  1. Assess for major risk factors: coagulopathy, shock, or chronic liver disease
  2. If ANY major risk factor present: Initiate low-dose PPI or H2RA regardless of enteral feeding status 1, 2
  3. If NO major risk factors present: Do not initiate SUP, even if mechanically ventilated 1, 2
  4. Daily reassessment: Discontinue SUP immediately when risk factors resolve 1, 2
  5. Before ICU transfer: Review and discontinue SUP if no ongoing indication 1, 2

The evidence strongly supports moving away from universal SUP in all ICU patients toward a risk-stratified approach that balances bleeding prevention against potential harms including infectious complications and unnecessary medication burden. 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Indications for PPI Inhibitors in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stress ulcer prophylaxis in the intensive care unit.

Current opinion in critical care, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.